Application Sponsors
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Discontinued | 003 |
Application Products
001 | TABLET;ORAL | 20MG | 0 | NADOLOL | NADOLOL |
002 | TABLET;ORAL | 40MG | 0 | NADOLOL | NADOLOL |
003 | TABLET;ORAL | 80MG | 0 | NADOLOL | NADOLOL |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-09-13 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
VGYAAN
cder:Array
(
[0] => Array
(
[ApplNo] => 212856
[companyName] => VGYAAN
[docInserts] => ["",""]
[products] => [{"drugName":"NADOLOL","activeIngredients":"NADOLOL","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"NADOLOL","activeIngredients":"NADOLOL","strength":"40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"NADOLOL","activeIngredients":"NADOLOL","strength":"80MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/13\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-09-13
)
)